Answers are grounded in this paper and cite their sources.
The novel class of GABA-A receptor selective positive allosteric modulator antidepressants (GASPAMAs) has brought forth significant improvement and positive impact to the management of patients with depression disorders in clinical practice "
No takes yet. Share an insight, caveat, or question.
Fasipe et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: